These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37949354)

  • 41. Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis.
    Hollin IL; Janssen E; Kelley MA; Bridges JFP
    BMC Med Inform Decis Mak; 2021 Feb; 21(1):44. PubMed ID: 33549068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Controlling for Scale Heterogeneity Better Explain Respondents' Preference Segmentation in Discrete Choice Experiments? A Case Study of US Health Insurance Demand.
    Karim S; Craig BM; Poteet S
    Med Decis Making; 2021 Jul; 41(5):573-583. PubMed ID: 33703964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.
    Postmus D; Richard S; Bere N; van Valkenhoef G; Galinsky J; Low E; Moulon I; Mavris M; Salmonsson T; Flores B; Hillege H; Pignatti F
    Oncologist; 2018 Jan; 23(1):44-51. PubMed ID: 29079638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure.
    Highland KB; Crawford R; Classi P; Morrison R; Doward L; Nelsen AC; Castillo H; Mathai SC; DuBrock HM
    Health Qual Life Outcomes; 2021 Aug; 19(1):202. PubMed ID: 34429110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Which Factors Are Considered by Patients When Considering Total Joint Arthroplasty? A Discrete-choice Experiment.
    Salimy MS; Humphrey TJ; Katakam A; Melnic CM; Heng M; Bedair HS
    Clin Orthop Relat Res; 2023 Mar; 481(3):427-437. PubMed ID: 36111881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Communicating Test Results from a General Health Check: Preferences from a Discrete Choice Experiment Survey.
    Grauman Å; Hansson M; James S; Hauber B; Veldwijk J
    Patient; 2021 Sep; 14(5):649-660. PubMed ID: 33778921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What factors influence HIV testing? Modeling preference heterogeneity using latent classes and class-independent random effects.
    Ostermann J; Flaherty BP; Brown DS; Njau B; Hobbie AM; Mtuy TB; Masnick M; Mühlbacher AC; Thielman NM
    J Choice Model; 2021 Sep; 40():. PubMed ID: 35422879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Barnes H; Brown Z; Burns A; Williams T
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012621. PubMed ID: 30701543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What matters most to patients with multiple myeloma? A Pan-European patient preference study.
    Janssens R; Lang T; Vallejo A; Galinsky J; Morgan K; Plate A; De Ronne C; Verschueren M; Schoefs E; Vanhellemont A; Delforge M; Schjesvold F; Cabezudo E; Vandebroek M; Stevens H; Simoens S; Huys I
    Front Oncol; 2022; 12():1027353. PubMed ID: 36523996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
    Lowery MM; Hill NS; Wang L; Rosenzweig EB; Bhat A; Erzurum S; Finet JE; Jellis CL; Kaur S; Kwon DH; Nawabit R; Radeva M; Beck GJ; Frantz RP; Hassoun PM; Hemnes AR; Horn EM; Leopold JA; Rischard FP; Mehra R;
    J Am Coll Cardiol; 2023 Nov; 82(21):1989-2005. PubMed ID: 37968017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
    Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
    Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries.
    Panattoni L; Kearney M; Land N; Flottemesch T; Sullivan P; Kirker M; Bharmal M; Hauber B
    Pharmacoeconomics; 2024 Aug; 42(8):895-909. PubMed ID: 38472738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient Preferences in the Treatment of Hemophilia A: A Best-Worst Scaling Case 3 Analysis.
    Mühlbacher AC; Sadler A; Lamprecht B; Juhnke C
    Value Health; 2020 Jul; 23(7):862-869. PubMed ID: 32762987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
    Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
    J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference.
    Xiao J; Wang F; Wang M; Ma Z
    Health Expect; 2022 Jun; 25(3):959-970. PubMed ID: 35049117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study.
    Currie BM; Davies EW; Beaudet A; Stassek L; Kleinman L; Baughman RP
    BMC Pulm Med; 2021 Nov; 21(1):365. PubMed ID: 34772372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class.
    Dufour R; Pruett J; Hu N; Lickert C; Stemkowski S; Tsang Y; Lane D; Drake W
    J Med Econ; 2017 Nov; 20(11):1178-1186. PubMed ID: 28762848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension.
    Taichman DB; McGoon MD; Harhay MO; Archer-Chicko C; Sager JS; Murugappan M; Chakinali MM; Palevsky HI; Gallop R
    Mayo Clin Proc; 2009 Jul; 84(7):586-92. PubMed ID: 19567712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.